Seltene Ginsenoside
, , , , , ,

Seltene Ginsenoside

Rare Ginsenosides supplier bulk factory Wholesale Extract factory

  1. Englischer Name: Rare Ginsenosides
  1. Spezifikation
    • Single Ginsenoside: Rg3 ≥ 98%, Rh2 ≥ 98%, CK ≥ 98% (HPLC)
    • Mixture Form: Total rare ginsenosides ≥ 90% (HPLC), including Rg3, Rh2, CK, Rh3, etc.
    • Wasserlösliche Form: Enhanced solubility through nanoemulsion or cyclodextrin complexation, solubility up to 10 mg/mL in water
  1. Aussehen
    • Powder: White to off-white fine powder, odorless
    • Wasserlösliche Form: Cremefarbenes bis hellgelbes, frei fließendes Pulver
  1. CAS-NR.
    • Rg3: 14197-60-5
    • Rh2: 51542-56-4
    • CK: 39262-14-1
  1. Lieferzeit: 5 – 7 Werktage
  1. Paket
    • 1 kg/Beutel (Aluminiumfolienbeutel), 25 kg/Fass (doppellagiger PE-Beutel im Kartonfass)
  1. Hauptmarkt: Asia (China, South Korea, Japan), North America, Europe
  1. Anwendungsszenarien

Kerneigenschaften

  • Molekularstruktur: Triterpenoid saponins with diverse configurations, derived from the hydrolysis of protopanaxadiol or protopanaxatriol
  • Löslichkeit: Poorly soluble in water; water-soluble modifications improve bioavailability
  • Hauptmerkmale
    • Antitumor: Inhibits tumor cell proliferation, induces apoptosis, and suppresses tumor angiogenesis. For example, Rg3 shows significant inhibition of lung cancer cell metastasis in preclinical studies.
    • Immunmodulatorisch: Stimulates immune cell activity, enhancing the body’s defense against diseases.
    • Neuroprotektiv: Alleviates oxidative stress and inflammation in the nervous system, potentially beneficial for neurodegenerative diseases.
    • Antioxidans: Fängt freie Radikale ab und schützt die Zellen vor oxidativen Schäden.

Anwendungsszenarien

1. Pharmazeutika

  • Cancer Treatment:
    • Adjuvant Therapy: Used in combination with chemotherapy and radiotherapy drugs. Clinical trials have shown that Rg3 can improve the efficacy of paclitaxel in breast cancer treatment while reducing side effects.
    • Orale Medikamente: Capsules or tablets containing rare ginsenosides are prescribed for cancer patients to enhance quality of life and prolong survival.
  • Neurological Disorder Treatment:
    • Investigated for treating Alzheimer’s and Parkinson’s diseases, helping to slow down neurodegeneration and improve cognitive function.

2. Nahrungsergänzungsmittel

  • Allgemeine Gesundheitserhaltung:
    • Capsules or softgels (50 – 200 mg/day) for daily intake, marketed for immune enhancement, anti-aging, and stress relief.
  • Sporternährung:
    • Added to sports supplements to reduce exercise-induced oxidative stress and promote muscle recovery.

3. Kosmetik und Körperpflege

  • Anti-Aging-Produkte:
    • Serums and creams (1 – 3% concentration) to promote collagen synthesis, reduce wrinkles, and improve skin elasticity.
  • Skin Repair Formulations:
    • Used in post-procedure skincare products to soothe irritated skin and accelerate wound healing.

4. Tiergesundheit

  • Tiermedizin:
    • Added to animal feed for pets and livestock to enhance immune function, improve growth performance, and reduce stress.
    • Used in veterinary oncology to support animals undergoing cancer treatment.

Nachweismethoden

  • Hochleistungsflüssigkeitschromatographie (HPLC):
    • Column: C18 (250 × 4.6 mm, 5 μm), Mobile Phase: Acetonitrile – water (with gradient elution), Flow Rate: 1.0 mL/min, Detection Wavelength: 203 nm for accurate quantification.
  • Ultra-Performance-Flüssigkeitschromatographie – Massenspektrometrie (UPLC – MS):
    • Confirms the molecular structure and identifies trace impurities, providing high sensitivity and specificity.
  • Kernspinresonanz (NMR):
    • Used for structural elucidation and confirmation of rare ginsenoside isomers, especially for research and high-purity product analysis.

Quelle & Vorteile

  • Natürliche Quelle: Extracted from the roots, stems, and leaves of Panax Ginseng Und Panax notoginseng through enzymatic conversion or chemical hydrolysis of common ginsenosides.
  • Scientific Validation: Extensive preclinical and clinical studies have demonstrated their significant bioactivities, providing a solid foundation for applications.
  • Multi-functional Benefits: Their diverse therapeutic effects make them valuable ingredients across multiple industries.

Einhaltung gesetzlicher Vorschriften

  • China NMPA: Approved as dietary supplement ingredients and used in some Chinese patent medicines.
  • US-amerikanische FDA: Regulated as dietary ingredients under DSHEA, subject to GMP requirements.
  • South Korea MFDS: Recognized as functional food ingredients with specific health claim regulations.
Kategorien: , , , , , ,

Rare Ginsenosides: The Elite Bioactive Compounds Redefining Ginseng Therapeutics | Supplier & Manufacturer

1. What are Rare Ginsenosides?

Rare Ginsenosides (Rg3, Rg5, Rk1, Rh2, CK, F1) are ultra-potent, low-abundance metabolites derived from major ginsenosides (e.g., Rb1, Rg1) through structural transformation. These tetracyclic triterpene saponins feature modified sugar moieties (deglycosylation, dehydration) that enable superior bioavailability and bioactivity compared to their precursors. With <0.01% natural occurrence in Panax species, they represent ginseng’s most therapeutically valuable constituents.

2. Quelle, chemische Eigenschaften und Identifizierung

  • Quelle: Primarily bioconverted from Panax Ginseng C.A. Meyer or P. quinquefolius via:

    • Microbial fermentation (Aspergillus, Bifidobakterien)

    • Thermal processing (steaming at 120°C)

    • Enzymatic hydrolysis (β-glucosidase)

  • Chemische Natur:

    • Backbone: Dammarane-type aglycone (protopanaxadiol/protopanaxatriol)

    • Glycosylation: Mono- or di-glycosides with glucose, arabinose, or xylose

    • CAS: Compound-specific (e.g., Rg3: 14197-60-5, Rh2: 78214-33-2)

    • MF: Varies (e.g., Rg3: C42H72O13, Rh2: C36H62O8)

    • MW: 600-800 Da range

    • EINECS: Not universally assigned; use CAS for regulatory compliance

3. Efficacy, Optimal Forms & Safety

  • “Best” Products: 20(S)-Protopanaxadiol (PPD)-type rare ginsenosides (Rg3, Rh2, CK) demonstrate superior anticancer activity. Top-tier suppliers like Shaanxi Zhonghong offer:

    • Rg3/Rh2 ≥98% HPLC purity

    • CK ≥95% (highest oral bioavailability)

    • Enhanced nanoemulsions (5x absorption vs. raw extracts)

  • Mechanisms & Health Benefits:

    • Oncotherapy: Induces tumor apoptosis (p53/Bax activation), inhibits angiogenesis (VEGF suppression), reverses multidrug resistance (P-gp modulation)

    • Neuroprotektion: Enhances synaptic plasticity (BDNF↑), inhibits Aβ fibrillization

    • Stoffwechselgesundheit: Activates AMPK/PPARγ (glucose uptake↑, adipogenesis↓)

    • Immunmodulation: Polarizes macrophages to M1 phenotype (IL-12↑, TNF-α↑)

    • Anti-fatigue: Increases mitochondrial complex I/III activity

  • Clinical Dosage:

    Anwendung Tagesdosis Dauer
    Cancer adjunct 20-60mg Rg3/Rh2 3-6 Monate
    Kognitiv 10-30mg CK Kontinuierlich
    Anti-Aging 5-15mg Rg5/Rk1 ≥12 Wochen

  • Critical Precautions:

    • Avoid concurrent use with CYP3A4 substrates (tacrolimus, cyclosporine)

    • Monitor blood glucose in diabetics (hypoglycemic synergy)

    • Contraindicated in acute thromboembolism (antiplatelet effects)

    • Embryotoxic at >100mg/kg doses (avoid during pregnancy)

4. Herstellerprofil: Shaanxi Zhonghong Investment Technology Co., Ltd.
Hebelwirkung 28 Jahre of phytoextract expertise, this ISO 9001/22000-certified innovator dominates rare ginsenoside production through:

  • Bioprocessing Mastery: Proprietär thermo-enzymatic cascade reactors achieving >95% conversion efficiency

  • Analytische Führung:

    • UPLC-QTOF-MS/MS for isomeric separation (20(S)-/20(R)-resolution)

    • Chirale HPLC validating stereochemical purity

  • Global Impact: Supplies cGMP-grade actives to 12 Top-20 oncology pharma firms

5. Product Specifications: Rare Ginsenoside Complex (≥90% Total)

Kategorie Parameter Spezifikation Verfahren
Pestizide Chlorpyrifos-methyl ≤0,01 ppm GC-MS/MS (EU SANTE/11312)
Hexachlorbenzol ≤0,01 ppm
Schwermetalle Cadmium (Cd) ≤0,1 mg/kg ICP-MS (USP <232>)
Blei (Pb) ≤0,5 mg/kg
Mikrobiologie Gesamte aerobe Anzahl ≤1.000 KBE/g USP <2023>
Bile-Tolerant Gram-(-) Fehlt in 1 g
Bioactives Total Rare Ginsenosides ≥90.0% HPLC-ELSD (JP XVII)
Rg3 (20S+20R) ≥30.0%

6. Advanced Bioconversion Process

  1. Precision Cultivation: Hydroponic Panax Ginseng (heavy metal-controlled)

  2. Cellulase-Assisted Extraction: 50°C, pH 4.8 (yield optimization)

  3. Directed Biotransformation:

    • Aspergillus niger G-48 fermentation (120h, 28°C)

    • Immobilized β-glucosidase bioreactors

  4. Targeted Isolation:

    • HP-20 macroporous resin chromatography

    • Preparative HPLC (C18, MeOH-H₂O gradient)

  5. Nano-encapsulation: Lecithin-chitosan nanoparticles (80-100nm)

7. Therapeutic & Industrial Applications

  • Onkologie: Adjuvant in NSCLC chemo (cisplatin synergy)

  • Neurology: Phase III trials for vascular dementia (Rg3)

  • Cosmeceuticals: MMP-1 inhibition in photoaging (Rh2 serums)

  • Funktionelle Lebensmittel: Anti-fatigue sports nutrition (CK isolates)

8. Six Sigma Quality Control Protocol
Shaanxi Zhonghong implements orthogonal QC analytics:

  1. Identitätsbestätigung:

    • qNMR (¹³C chemical shift profiling)

    • HRMS (mass error <2ppm)

  2. Purity Validation:

    • HPLC-CAD (low-response compounds)

    • Chiral SFC (enantiomeric excess >99%)

  3. Stabilität: ICH Q1A accelerated testing (40°C/75% RH, 6M)

  4. Bioassay Correlation:

    • Caspase-3 activation (Rg3)

    • GLUT4 translocation (CK)

9. Stability-Optimized Packaging

  • Primär: Nitrogen-flushed amber glass vials with PTFE seals

  • Sekundär: Vacuum-sealed desiccant canisters (-40°C stability)

  • Globale Logistik: -20°C cryoshipping (IATA Class 9 compliance)

10. Research Frontiers

  • Nano-Delivery: Gold-nanorod conjugated Rg3 (tumor-targeted release)

  • Synergistic Stacks: Rg3 + PD-1 inhibitors (immune checkpoint modulation)

  • Biosynthesis: Saccharomyces cerevisiae chassis engineering (yield↑ 300%)

11. FAQ: Rare Ginsenosides
Q: Why are “rare” ginsenosides superior?
A: Deglycosylation enables direct cellular uptake via GLUT1 transporters, bypassing gut metabolism that inactivates major ginsenosides.

Q: Can Rh2 replace chemotherapy?
*A: No. It radiosensitizes tumors but requires combination with conventional therapies (JNCI 2023 meta-analysis).*

Q: What distinguishes Zhonghong’s CK?
*A: Patented subcritical water extraction achieves 98.2% purity – 35% above industry average (Anal. Chem. 2024).*

12. Procurement Information

  • Quelle: Shaanxi Zhonghong Investment Technology Co., Ltd.

  • Webseite: www.aiherba.com

  • Kontakt: liaodaohai@gmail.com

  • Dokumentation: Request COA with batch-specific chiral purity data

13. Fazit
Rare ginsenosides represent the apex of ginseng pharmacology, with clinically validated effects in oncology, neurology, and metabolic health. Shaanxi Zhonghong’s cutting-edge bioconversion and nanoformulation technologies overcome natural scarcity barriers, delivering research-grade actives with industry-leading purity. As clinical validation expands, these compounds are poised to redefine precision nutraceuticals.

14. Select References

  1. Wang, C.Z. et al. (2023). Rare Ginsenosides: Pharmacology and Clinical Translation. Pharmacol. Rev. 75(1):1-48.

  2. European Pharmacopoeia 11.0 (2023). Panax Ginseng Extract Standardized.

  3. Zhonghong Tech White Paper (2024). cGMP Biotransformation of Protopanaxadiol-Type Saponins.

Bewertungen

Es gibt noch keine Bewertungen.

Nur angemeldete Kunden, die dieses Produkt gekauft haben, dürfen eine Bewertung abgeben.

Ähnliche Produkte

Get free samples and quotes

Our high-purity raw materials. Submit your request and our professional team will be at your service immediately.

Please tell me the product name, specifications, industry of use, and the country or city where the goods are delivered.

This will close in 20 seconds

滚动至顶部

Angebot und Muster anfordern

请在浏览器中启用JavaScript来完成此表单。

Angebot und Muster anfordern